Literature DB >> 14760466

Laparoscopy for adhesions.

Petachia Reissman1, Ram M Spira.   

Abstract

Intestinal and abdominal adhesions may be responsible for a variety of clinical conditions, including chronic recurrent small-bowel obstruction, acute small-bowel obstruction, closed-loop bowel obstruction and, debatably, abdominal or pelvic pain. Experience in laparoscopic surgery has increased at a rapid pace, thus adhesions are no longer considered a contraindication to treatment of these conditions. In recent years, numerous publications have reported the feasibility, safety, and favorable outcome of laparoscopic intervention in various adhesion-related conditions. As adhesions are the most common cause of recurrent or acute bowel obstruction, this review will focus on the laparoscopic management of these conditions and outline the technical considerations, indications, contraindications, and results.

Entities:  

Mesh:

Year:  2003        PMID: 14760466     DOI: 10.1177/107155170301000405

Source DB:  PubMed          Journal:  Semin Laparosc Surg        ISSN: 1071-5517


  4 in total

1.  Laparoscopic Versus Open Loop Ileostomy Reversal: Is there an Advantage to a Minimally Invasive Approach?

Authors:  Monica T Young; Grace S Hwang; Gopal Menon; Timothy F Feldmann; Mehraneh D Jafari; Fariba Jafari; Eden Perez; Alessio Pigazzi
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

Review 2.  Laparoscopic management of adhesive small bowel obstruction.

Authors:  R Essani; R Bergamaschi
Journal:  Tech Coloproctol       Date:  2008-11-18       Impact factor: 3.781

3.  Laparoscopic treatment of a postoperative small bowel obstruction.

Authors:  Marc Neff; Brian Schmidt
Journal:  JSLS       Date:  2010 Jan-Mar       Impact factor: 2.172

4.  Laparoscopic management as the initial treatment of acute small bowel obstruction.

Authors:  Henry J Lujan; Aeyal Oren; Gustavo Plasencia; Gustavo Canelon; Eddie Gomez; Alejandro Hernandez-Cano; Moises Jacobs
Journal:  JSLS       Date:  2006 Oct-Dec       Impact factor: 2.172

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.